암센터 국문 논문 목록
학술지 |
책임저자 제1저자 |
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor) |
|
Sung-In Jang
|
Sung-In Jang:정원정:. Effects of life-sustaining treatment plans on healthcare expenditure and healthcare utilization
BMC HEALTH SERVICES RESEARCH. 2023-11-10; 2023;
23(1):1236~.
IF 2.8 (2022)
|
정원정 (암지식정보센터)
|
|
명승권 (임상간호학과)
|
명승권:Dung V. Tran:Xuan Quy Luu, Huong T.T. Tran. Dietary and supplementary vitamin C intake and the risk of lung cancer: A meta-analysis of cohort studies
ONCOLOGY LETTERS. 2023-11-10; 2023;
27(1):10~.
IF 2.9 (2022)
|
Van Dung TRAN (암관리학과)
|
|
임명철 (희귀ㆍ소아암연구과)
|
임명철:김지현, Hyun-Woong Cho:박상윤, 박은영, Kyung-Hee Han, Eun Taeg Kim, Jae-Kwan Lee, Robert Armbrust, Christina Fotopoulou. Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023-11-10; 2023;
33(12):1913~1920.
IF 4.8 (2022)
|
김지현 (산부인과)
|
|
조현순 (암AI디지털헬스학과)
|
조현순:Chang-Mo Oh:Sanghee Lee, 권회준, 황보빈. Prevalence of pre-existing lung diseases and their association with income level among patients with lung cancer: a nationwide population-based case-control study in South Korea
BMJ OPEN RESPIRATORY RESEARCH. 2023-11-08; 2023;
10(1):e001772~.
IF 4.1 (2022)
|
Chang-Mo Oh
|
|
Byung Kiu Park
|
Byung Kiu Park:박미림:서진경, 이준아, 박현진, 박은영, 유종우, 임명철, 박상윤. Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin
CANCERS. 2023-11-04; 2023;
15(21):5290~.
IF 5.2 (2022)
|
박미림 (희귀ㆍ소아암연구과)
|
|
김선영 (암AI디지털헬스학과)
|
김선영:Insang Song:오진경. Role of geographic characteristics in the spatial cluster detection of cancer: Evidence in South Korea, 1999-2013
ENVIRONMENTAL RESEARCH. 2023-11-01; 2023;
236(2):116841~.
IF 8.3 (2022)
|
Insang Song
|
|
Youngja H Park, Jung Eun Lee
|
Youngja H Park, Jung Eun Lee:김태월, Gyumin Kang:. The effects of dietary self-monitoring intervention on anthropometric and metabolic changes via a mobile application or paper-based diary: a randomized trial
NUTRITION RESEARCH AND PRACTICE. 2023-10-30; 2023;
17(6):1238~1254.
IF 2.4 (2022)
|
김태월 (암예방사업부)
|
|
박종배 (암의생명과학과)
|
박종배:김찬일:박성민, 김성수, 권형준, 하석준, 하경희, 박산하, 박승민, 김경희, 김윤희, 김종헌, Sooheon Kim, Weiwei Lin, Saewhan Park, Tae Hoon Kim. Fam20C Kinase as A Key Regulator of Bevacizumab Resistance in Mesenchymal Glioblastoma
ADVANCED THERAPEUTICS. 2023-10-30; 2023;
:~.
IF 4.6 (2022)
|
김찬일 (암의생명과학과)
|
|
임명철 (희귀ㆍ소아암연구과)
|
임명철:김지현, Se Ik Kim:박은영, 박상윤, Hyeong In Ha, Jae-Weon Kim, Robert L. Coleman, Robert E. Bristow, Christina Fotopoulou. Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis
GYNECOLOGIC ONCOLOGY. 2023-10-28; 2023;
179:24~32.
IF 4.7 (2022)
|
김지현 (산부인과)
|
|
김번 (암진단연구과)
|
김번:Joo Hyun Park:조현순. Risk factors for colorectal cancer in a fecal immunochemical test-positive group: The National Health Insurance Service-National Health Screening Cohort
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2023-10-19; 2023;
:~.
IF 4.1 (2022)
|
Joo Hyun Park
|